• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染性休克期间高迁移率族蛋白B1的血浆浓度

High-mobility group box 1 protein plasma concentrations during septic shock.

作者信息

Gibot Sébastien, Massin Frédéric, Cravoisy Aurélie, Barraud Damien, Nace Lionel, Levy Brune, Bollaert Pierre-Edouard

机构信息

Hôpital Central, Service de Réanimation Médicale, 29 avenue du Maréchal de Lattre de Tassigny, 54000, Nancy, France.

出版信息

Intensive Care Med. 2007 Aug;33(8):1347-53. doi: 10.1007/s00134-007-0691-2. Epub 2007 May 25.

DOI:10.1007/s00134-007-0691-2
PMID:17525840
Abstract

OBJECTIVE

To investigate plasma high-mobility group box 1 protein (HMGB1) concentration and its relationship with organ dysfunction and outcome in septic shock patients.

DESIGN AND SETTING

Prospective, noninterventional study. Medical adult intensive care unit at a university hospital in France.

PATIENTS

42 critically ill patients with septic shock.

METHODS

Arterial blood was drawn within 12 h of admission for the measurement of plasma HMGB1 concentration by ELISA. Repeated sampling was performed on days 3, 7, and 14.

RESULTS

Median HMGB1 concentration was 4.4 ng/ml (IQR 1.2-12.5) at admission, with no difference between survivors and nonsurvivors. A positive correlation was observed between HMGB1 and SOFA score and lactate, and procalcitonin concentrations. There was a progressive but statistically nonsignificant decline in HMGB1 concentration among the survivors, while nonsurvivors showed an increase in HMGB1 level between days 1 and 3. SOFA score and lactate and procalcitonin concentrations did not vary significantly between days 1 and 3. When measured on day 3, HMGB1 discriminated survivors from nonsurvivors with 66% sensitivity and 67% specificity, and concentration greater than 4 ng/ml was associated with an odds ratio of death of 5.5 (95% CI 1.3-23.6).

摘要

目的

探讨脓毒性休克患者血浆高迁移率族蛋白B1(HMGB1)浓度及其与器官功能障碍和预后的关系。

设计与背景

前瞻性、非干预性研究。法国一家大学医院的内科成人重症监护病房。

患者

42例脓毒性休克重症患者。

方法

入院后12小时内采集动脉血,采用酶联免疫吸附测定法(ELISA)检测血浆HMGB1浓度。在第3、7和14天进行重复采样。

结果

入院时HMGB1浓度中位数为4.4 ng/ml(四分位间距1.2 - 12.5),存活者与非存活者之间无差异。观察到HMGB1与序贯器官衰竭评估(SOFA)评分、乳酸及降钙素原浓度呈正相关。存活者中HMGB1浓度呈逐渐下降趋势,但无统计学意义,而非存活者在第1天至第3天HMGB1水平升高。第1天至第3天SOFA评分、乳酸及降钙素原浓度无显著变化。在第3天测量时,HMGB1区分存活者与非存活者的敏感度为66%,特异度为67%,浓度大于4 ng/ml时死亡比值比为5.5(95%可信区间1.3 - 23.6)。

相似文献

1
High-mobility group box 1 protein plasma concentrations during septic shock.感染性休克期间高迁移率族蛋白B1的血浆浓度
Intensive Care Med. 2007 Aug;33(8):1347-53. doi: 10.1007/s00134-007-0691-2. Epub 2007 May 25.
2
Dynamic change of procalcitonin, rather than concentration itself, is predictive of survival in septic shock patients when beyond 10 ng/mL.降钙素原动态变化而非浓度本身,在超过 10ng/mL 时对脓毒性休克患者的生存具有预测价值。
Shock. 2011 Dec;36(6):570-4. doi: 10.1097/SHK.0b013e31823533f9.
3
Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock.严重脓毒症和脓毒性休克患者中高迁移率族蛋白B1(HMGB1)持续升高。
Crit Care Med. 2005 Mar;33(3):564-73. doi: 10.1097/01.ccm.0000155991.88802.4d.
4
Prognostic evaluation of severe sepsis and septic shock: procalcitonin clearance vs Δ Sequential Organ Failure Assessment.严重脓毒症和感染性休克的预后评估:降钙素原清除率与Δ序贯器官衰竭评估。
J Crit Care. 2015 Feb;30(1):219.e9-12. doi: 10.1016/j.jcrc.2014.08.018. Epub 2014 Sep 10.
5
Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock.降钙素原在外科和内科脓毒性休克患者中的鉴别诊断价值
Crit Care Med. 2006 Jan;34(1):102-7. doi: 10.1097/01.ccm.0000195012.54682.f3.
6
Diagnostic and prognostic value of procalcitonin in patients with septic shock.降钙素原在感染性休克患者中的诊断及预后价值
Crit Care Med. 2004 May;32(5):1166-9. doi: 10.1097/01.ccm.0000126263.00551.06.
7
[The predictor value of peripheral blood procalcitonin levels in the evaluation of prognosis of patients with septic shock].[外周血降钙素原水平在脓毒性休克患者预后评估中的预测价值]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012 Aug;24(8):470-3.
8
Elevated Serum PCT in Septic Shock With Endotoxemia Is Associated With a Higher Mortality Rate.伴有内毒素血症的感染性休克患者血清降钙素原升高与较高的死亡率相关。
Medicine (Baltimore). 2015 Jul;94(27):e1085. doi: 10.1097/MD.0000000000001085.
9
High Mobility Group Box 1 and Interleukin 6 at Intensive Care Unit Admission as Biomarkers in Critically Ill COVID-19 Patients.入住重症监护病房的危重症 COVID-19 患者的高迁移率族蛋白 B1 和白细胞介素 6 作为生物标志物。
Am J Trop Med Hyg. 2021 May 3;105(1):73-80. doi: 10.4269/ajtmh.21-0165.
10
Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock.降钙素原与细胞因子水平:与小儿感染性休克中器官功能衰竭及死亡率的关系
Crit Care Med. 2000 Jul;28(7):2591-4. doi: 10.1097/00003246-200007000-00068.

引用本文的文献

1
Biomarkers as Beacons: Illuminating Sepsis-Associated Hepato-Renal Injury.作为灯塔的生物标志物:照亮脓毒症相关肝肾损伤
Int J Mol Sci. 2025 May 18;26(10):4825. doi: 10.3390/ijms26104825.
2
High Mobility Group Box 1 (HMGB1): Potential Target in Sepsis-Associated Encephalopathy.高迁移率族蛋白 B1(HMGB1):脓毒症相关性脑病的潜在靶点。
Cells. 2023 Apr 4;12(7):1088. doi: 10.3390/cells12071088.
3
The effects of etomidate on expression of high mobility group box 1 via the nuclear factor kappa B pathway in rat model of sepsis.依托咪酯通过核因子-κB 通路对脓毒症大鼠模型高迁移率族蛋白 B1 表达的影响。

本文引用的文献

1
High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis: a prospective study.疑似社区获得性感染和脓毒症患者的高迁移率族蛋白盒1:一项前瞻性研究
Crit Care. 2007;11(2):R32. doi: 10.1186/cc5715.
2
The innate signaling of dangers and the dangers of innate signaling.危险的先天信号传导与先天信号传导的危险。
Nat Immunol. 2006 Dec;7(12):1237-42. doi: 10.1038/ni1420.
3
Factors masking HMGB1 in human serum and plasma.人血清和血浆中掩盖高迁移率族蛋白B1(HMGB1)的因素。
Libyan J Med. 2023 Dec;18(1):2182683. doi: 10.1080/19932820.2023.2182683.
4
Using heparan sulfate octadecasaccharide (18-mer) as a multi-target agent to protect against sepsis.使用硫酸乙酰肝素十八聚糖(18- mer)作为多靶点药物来防治脓毒症。
Proc Natl Acad Sci U S A. 2023 Jan 24;120(4):e2209528120. doi: 10.1073/pnas.2209528120. Epub 2023 Jan 17.
5
MicroRNA-23a-3p targeting of HMGB1 inhibits LPS-induced inflammation in murine macrophages .MicroRNA-23a-3p靶向HMGB1抑制小鼠巨噬细胞中脂多糖诱导的炎症反应
Exp Ther Med. 2022 May;23(5):322. doi: 10.3892/etm.2022.11251. Epub 2022 Mar 10.
6
Mortality at 180-days is affected by serum haptoglobin levels in septic patients with high magnitude serum high mobility group box-1 levels.血清高迁移率族蛋白B1水平较高的脓毒症患者中,180天死亡率受血清触珠蛋白水平影响。
Acute Med Surg. 2022 Feb 1;9(1):e726. doi: 10.1002/ams2.726. eCollection 2022 Jan-Dec.
7
ANA positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies.胸腔积液中的 ANA 阳性和补体水平是鉴别狼疮性胸膜炎与其他病因胸腔积液的潜在诊断标志物。
Lupus Sci Med. 2021 Nov;8(1). doi: 10.1136/lupus-2021-000562.
8
Association of plasma level of high-mobility group box-1 with necroptosis and sepsis outcomes.高迁移率族蛋白 B1 血浆水平与脓毒症发生发展及预后的关系
Sci Rep. 2021 May 4;11(1):9512. doi: 10.1038/s41598-021-88970-6.
9
Acute e-cig inhalation impacts vascular health: a study in smoking naïve subjects.急性电子烟吸入对血管健康的影响:一项在吸烟新手中的研究。
Am J Physiol Heart Circ Physiol. 2021 Jan 1;320(1):H144-H158. doi: 10.1152/ajpheart.00628.2020. Epub 2020 Nov 20.
10
Association between thrombomodulin and high mobility group box 1 in sepsis patients.脓毒症患者中血栓调节蛋白与高迁移率族蛋白B1之间的关联
World J Crit Care Med. 2020 Oct 18;9(4):63-73. doi: 10.5492/wjccm.v9.i4.63.
J Leukoc Biol. 2007 Jan;81(1):67-74. doi: 10.1189/jlb.0306196. Epub 2006 Oct 23.
4
HMGB1, a novel inflammatory cytokine.高迁移率族蛋白B1,一种新型炎症细胞因子。
Clin Chim Acta. 2007 Jan;375(1-2):36-42. doi: 10.1016/j.cca.2006.07.019. Epub 2006 Jul 25.
5
New high mobility group box 1 assay system.新型高迁移率族蛋白B1检测系统。
Clin Chim Acta. 2006 Oct;372(1-2):173-8. doi: 10.1016/j.cca.2006.04.016. Epub 2006 Jun 23.
6
Cryopyrin activates the inflammasome in response to toxins and ATP.冰晶蛋白响应毒素和三磷酸腺苷激活炎性小体。
Nature. 2006 Mar 9;440(7081):228-32. doi: 10.1038/nature04515. Epub 2006 Jan 11.
7
Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation.高迁移率族蛋白盒蛋白在弥散性血管内凝血患者器官衰竭预后中的血浆浓度及重要性
Thromb Haemost. 2005 Nov;94(5):975-9. doi: 10.1160/TH05-05-0316.
8
Should high mobility group box-1 protein (HMGB1) be measured in patients with severe sepsis and septic shock? If so, when, where, and how?对于严重脓毒症和脓毒性休克患者,是否应该检测高迁移率族蛋白B1(HMGB1)?如果是,何时、何地以及如何检测?
Crit Care Med. 2005 Mar;33(3):682-3. doi: 10.1097/01.ccm.0000155995.62327.93.
9
Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock.严重脓毒症和脓毒性休克患者中高迁移率族蛋白B1(HMGB1)持续升高。
Crit Care Med. 2005 Mar;33(3):564-73. doi: 10.1097/01.ccm.0000155991.88802.4d.
10
Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis.硬脂酰溶血磷脂酰胆碱对HMGB1释放的抑制作用:其在实验性脓毒症中治疗效果的一种额外机制
J Lipid Res. 2005 Apr;46(4):623-7. doi: 10.1194/jlr.C400018-JLR200. Epub 2005 Feb 1.